Verona Pharma, headquartered in Raleigh, wins a $ 219 million marketing deal in China

News Godzilla
Copyright 2021 novcog.com news network We rock so you don''t have to.


Verona Pharma, headquartered in Raleigh, wins a $ 219 million marketing deal in China Verona Pharma, headquartered in Raleigh, wins a $ 219 million marketing deal in China

RESEARCH TRIANGLE PARK – Verona Pharma has signed a $ 219 million contract to commercialize its first-in-class drug Ensifentrin for chronic obstructive pulmonary disease (COPD) in China. This week, the British clinical-stage biotech company headquartered in Raleigh announced that it has signed an agreement granting Nuance Pharma, a Shanghai-based specialty pharmaceutical company, the rights to..
previous post